Primary contact

myDNA is a genetic interpretation service that helps people to make better health, wellness and lifestyle decisions. The company's medication test promises to help users and their doctors personalize treatments by selecting the most appropriate medications based on how one's body metabolizes drugs. Also, its offering includes other tests that cover nutrition, skin anti-aging, fitness and more. The insights and recommendations found in each myDNA plan are delivered through the company's proprietary algorithms, combining the user's genetic insights with years of evidence from the scientific literature. In addition to its home turf of Australia, myDNA also has operations in New Zealand, USA, Canada, and the UK.
Primary contact

Funding 💰

Total A$19M
Select investors Light Warrior
Last update: October 8, 2020